MediciNova
MNOV
49 hedge funds and large institutions have $77.9M invested in MediciNova in 2019 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 21 increasing their positions, 12 reducing their positions, and 4 closing their positions.
75% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 12
0.04% more ownership
Funds ownership: 22.47% → 22.51% (+0.04%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2% less funds holding
Funds holding: 50 → 49 (-1)
16% less capital invested
Capital invested by funds: $93.2M → $77.9M (-$15.2M)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$674K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$441K |
| 3 |
State Street
Boston,
Massachusetts
|
+$402K |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$281K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$266K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$1.09M |
| 2 |
WC
Wexford Capital
West Palm Beach,
Florida
|
-$850K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$181K |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
-$76.5K |
| 5 |
Citigroup
New York
|
-$62.4K |
MNOV Hedge Fund Activity: Q3 2019 in Review
49 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in MediciNova (MNOV) for Q3 2019, worth a combined $77.9M — down 16% from $93.2M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of MNOV and 3 opened new positions — a net loss of 1 holder — while 12 trimmed existing stakes and 21 added.
The largest buyer was BlackRock, adding an estimated $674K. The largest seller was Millennium Management, exiting entirely with an estimated $1.09M sold.
- 49 institutional investors held MediciNova (MNOV) as of Q3 2019, down from 50 in Q2 2019.
- Funds reported $77.9M of MediciNova stock for Q3 2019, down 16% quarter-over-quarter.
- 3 funds opened new MediciNova positions in Q3 2019 and 4 closed out, a net change of -1 holder.
- The largest MediciNova buyer in Q3 2019 was BlackRock, an estimated $674K added.
- The largest MediciNova seller in Q3 2019 was Millennium Management, an estimated $1.09M sold.
Based on aggregated 13F filings for Q3 2019.